• DOI:10.1093/JN/138.1.49
Corpus ID: 4448835

Lycopene inhibits disease progression in patients with benign prostate hyperplasia.

@article{Schwarz2008LycopeneID,
  title={Lycopene inhibits disease progression in patients with benign prostate hyperplasia.},
  author={S. Schwarz and U. Obermueller-Jevic and E. Hellmis and W. Koch and G. Jacobi and H. Biesalski},
  journal={The Journal of nutrition},
  year={2008},
  volume={138 1},
  pages={
          49-53
        }
}

• S. Schwarz, U. Obermueller-Jevic, +3 authors H. Biesalski
• Published 2008
• Medicine
• The Journal of nutrition

Lycopene is a promising nutritional component for chemoprevention of prostate cancer (PCa). A possibly beneficial role of lycopene in patients diagnosed with benign prostate hyperplasia (BPH), who are at increased risk of developing PCa, has been suggested, although clinical data are lacking. Therefore, this pilot study aimed to investigate the effects of lycopene supplementation in elderly men diagnosed with BPH. A total of 40 patients with histologically proven BPH free of PCa were randomized… Expand

View on PubMed

academic.oup.com

Save to Library

Create Alert

Cite

Launch Research Feed